Skip to main navigation Skip to search Skip to main content

Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism

  • Martin R. Pollak*
  • , Edward M. Brown
  • , Yah Huei Wu Chou
  • , Steven C. Hebert
  • , Stephen J. Marx
  • , Beat Stelnmann
  • , Tatjana Levi
  • , Christine E. Seidman
  • , J. G. Seidman
  • *Corresponding author for this work
  • Brigham and Women’s Hospital
  • Harvard University
  • National Institutes of Health
  • University of Zurich

Research output: Contribution to journal › Journal Article › peer-review

986 Scopus citations

Abstract

We demonstrate that mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperpara-thyroidism (NSHPT), two inherited conditions characterized by altered calcium homeostasis. The Ca2+-sensing receptor belongs to the superfamily of seven membrane-spanning G protein-coupled receptors. Three nonconservative missense mutations are reported: two occur in the extracellular N-terminal domain of the receptor; the third occurs in the final intracellular loop. One mutated receptor identified in FHH individuals was expressed in X. laevis oocytes. The expressed wild-type receptor elicted large inward currents in response to perfused polyvalent cations; a markedly attenuated response was observed with the mutated protein. We conclude that the mammalian Ca2+-sensing receptor "sets" the extracellular Ca2+ level and is defective in individuals with FHH and NSHPT.

Original languageEnglish
Pages (from-to)1297-1303
Number of pages7
JournalCell
Volume75
Issue number7
DOIs
StatePublished - 31 12 1993
Externally publishedYes

Fingerprint

Dive into the research topics of 'Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism'. Together they form a unique fingerprint.

Cite this